Nobilis Health Corp (NYSEAMERICAN:HLTH) (TSE:NHC) saw a significant decline in short interest in October. As of October 15th, there was short interest totalling 1,017,411 shares, a decline of 2.8% from the September 28th total of 1,046,776 shares. Based on an average daily volume of 160,967 shares, the days-to-cover ratio is currently 6.3 days. Currently, 1.8% of the shares of the stock are sold short.
NYSEAMERICAN:HLTH opened at $0.74 on Friday. Nobilis Health has a 1-year low of $0.62 and a 1-year high of $1.70.
Nobilis Health (NYSEAMERICAN:HLTH) (TSE:NHC) last released its earnings results on Thursday, August 2nd. The healthcare company reported $0.01 earnings per share for the quarter, missing the consensus estimate of $0.03 by ($0.02). The business had revenue of $69.19 million during the quarter.
A hedge fund recently raised its stake in Nobilis Health stock. National Investment Services Inc. WI raised its stake in Nobilis Health Corp (NYSEAMERICAN:HLTH) (TSE:NHC) by 43.7% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 641,970 shares of the healthcare company’s stock after buying an additional 195,152 shares during the quarter. National Investment Services Inc. WI owned 0.82% of Nobilis Health worth $770,000 as of its most recent filing with the Securities and Exchange Commission.
About Nobilis Health
Nobilis Health Corp. owns and manages ambulatory surgical centers (ASCs), and acute-care and surgical hospitals in the United States. It operates through two segments, Medical Services and Marketing. The company's healthcare facilities provides surgical procedures in various clinical specialties, including orthopedic surgery, podiatric, vein and vascular, pain management, gastro- intestinal, gynecology, and general, as well as ear, nose, and throat.
Recommended Story: Should I follow buy, hold and sell recommendations?
Receive News & Ratings for Nobilis Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nobilis Health and related companies with MarketBeat.com's FREE daily email newsletter.